Retained Earnings (Accumulated Deficit) of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: GBP
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: TC BioPharm (Holdings) plc quarterly Retained Earnings (Accumulated Deficit) in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
TC BioPharm (Holdings) plc Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2024 was £52,559,029, a 30% decline year-over-year.
Source SEC data: View on sec.gov

Retained Earnings (Accumulated Deficit), Quarterly (GBP)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Retained Earnings (Accumulated Deficit) (GBP)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	£52,559,029	-£12,154,030	-30%	31 Dec 2024	20-F	09 May 2025	2024	FY
Q2 2024	£44,145,697			30 Jun 2024	6-K	25 Nov 2024	2024	Q2
Q1 2024	£42,159,144			31 Mar 2024	10-Q	15 May 2024	2024	Q1
Q4 2023	£40,404,999	-£7,030,203	-21%	31 Dec 2023	20-F	09 May 2025	2024	FY
Q4 2022	£33,374,796			31 Dec 2022	10-K	01 Apr 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.